Scientists scan brains to unlock Ketamine's depression secret
NCT ID NCT06668571
Summary
This study aims to understand how a single dose of ketamine affects specific brain chemicals in people with depression that hasn't responded to other treatments. Researchers will use MRI brain scans and blood tests to measure changes in chemicals linked to mood, comparing them to changes in depression symptoms. The goal is to learn more about how ketamine works, not to provide a long-term treatment.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TREATMENT RESISTANT DEPRESSION (TRD) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Mayo Clinic in Rochester
RECRUITINGRochester, Minnesota, 55905, United States
Contact
Conditions
Explore the condition pages connected to this study.